Melissa officinalis Regulates Lipopolysaccharide-Induced BV2 Microglial Activation via MAPK and Nrf2 Signaling
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neuroinflammation and microglial activation play critical roles in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Modulating microglial activation may help prevent the progression of these disorders. This study aimed to investigate the effects and mechanisms of Melissa officinalis ethanol extract on lipopolysaccharide (LPS)-induced microglial activation in BV2 cells. Cell viability and nitric oxide (NO) production were assessed using MTT assay and Griess reagent, while inflammatory cytokine levels were measured by qPCR. Key inflammatory pathways, including MAPK, TLR4, and antioxidant biomarkers, were analyzed through western blot and immunofluorescence. Rosmarinic acid content in M. officinalis was determined using high-performance liquid chromatography (HPLC). The results demonstrated that M. officinalis ethanol extract significantly inhibited LPS-induced NO production and reduced inflammatory cytokine expression. Additionally, it downregulated inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TLR4, NF-κB, and MAPK signaling pathways (p38, JNK, ERK), while increasing the expression of antioxidant markers, including Nrf2, HO-1, catalase, and SOD2. In conclusion, M. officinalis ethanol extract exerts neuroprotective effects by modulating inflammation and enhancing antioxidant defenses, suggesting its potential in the prevention and treatment of inflammation-related neurodegenerative diseases.
Abstract
Neuroinflammation and microglial activation play critical roles in neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Modulating microglial activation may help prevent the progression of these disorders. This study aimed to investigate the effects and mechanisms of Melissa officinalis ethanol extract on lipopolysaccharide (LPS)-induced microglial activation in BV2 cells. Cell viability and nitric oxide (NO) production were assessed using MTT assay and Griess reagent, while inflammatory cytokine levels were measured by qPCR. Key inflammatory pathways, including MAPK, TLR4, and antioxidant biomarkers, were analyzed through western blot and immunofluorescence. Rosmarinic acid content in M. officinalis was determined using high-performance liquid chromatography (HPLC). The results demonstrated that M. officinalis ethanol extract significantly inhibited LPS-induced NO production and reduced inflammatory cytokine expression. Additionally, it downregulated inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TLR4, NF-κB, and MAPK signaling pathways (p38, JNK, ERK), while increasing the expression of antioxidant markers, including Nrf2, HO-1, catalase, and SOD2. In conclusion, M. officinalis ethanol extract exerts neuroprotective effects by modulating inflammation and enhancing antioxidant defenses, suggesting its potential in the prevention and treatment of inflammation-related neurodegenerative diseases.
참고문헌 (33)
- Perry VH, "Microglia in neurodegenerative disease", Nat. Rev. Neurol, 6, pp.193~201 (2010)
- Heneka MT, "Innate immune activation in neurodegenerative disease", Nat. Rev. Immunol, 14, pp.463~477 (2014)
- Block ML, "Microglia and inflammation-mediated neurodegeneration : multiple triggers with a common mechanism", Prog. Neurobiol, 76, pp.77~98 (2005)
- Tang Y, "Differential roles of M1 and M2 Microglia in neurodegenerative diseases", Mol. Neurobiol, 53, pp.1181~1194 (2016)
- Liu T, "NF-kappaB signaling in inflammation", Signal Transduct. Target. Ther, 2, pp.17023~ (2017)
- Solleiro-Villavicencio H, "Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases", Front. Cell. Neurosci, 12, pp.114~ (2018)
- Gao C, "Microglia in neurodegenerative diseases : mechanism and potential therapeutic targets", Signal. Transduct. Target. Ther, 8, pp.359~ (2023)
- Gaikwad S, "Toll-like receptor-4 antagonism mediates benefits during neuroinflammation", Neural. Regen. Res, 11, pp.552~553 (2016)
- Li Y, "Role of toll-like receptor 4 in the regulation of the cell death pathway and neuroinflammation", Brain Res. Bull, 148, pp.79~90 (2019)
- Zusso M, "Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4", NF-kB pathway, 2019, pp.16, 148~
- Teter B, "Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis", Neurobiol. Dis, 127, pp.432~448 (2019)
- Sharma N, "Apocyanin, a microglial NADPH oxidase inhibitor prevents dopaminergic neuronal degeneration in lipopolysaccharide-induced Parkinson's disease model", Mol. Neurobiol, 53, pp.3326~3337 (2016)
- Onyango IG, "Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products(RAGE)", Mol. Cell Neurosci, 29, pp.333~343 (2005)
- Liu A, "HMGB-1", RAGE signaling inhibition by dioscin attenuates hippocampal neuron damage induced by oxygen-glucose deprivation, Exp. Ther. Med, pp.2020, 20[DOI]
- "2021 Alzheimer's disease facts and figures", Alzheimers Dement, 17, pp.327~406 (2021)
- Hou Y, "Ageing as a risk factor for neurodegenerative disease", Nat. Rev. Neurol, 15, pp.565~581 (2019)
- Nathan C, "Nitric oxide synthases : roles, tolls, and controls", Cell, 78, pp.915~918 (1994)
- Minghetti L, "Cyclooxygenase-2(COX-2)in inflammatory and degenerative brain diseases", J. Neuropathol. Exper. Neurol, 63, pp.901~910 (2004)
- Miraj S, "Melissa officinalis L : a review study with an antioxidant prospective", J. Evid. Based Complement. Altern. Med, 22, pp.385~394 (2017)
- Cicolari S, "Inflammaging and neurodegenerative diseases : role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease", Mech. Ageing Dev, 195, pp.111467~ (2021)
- Holbrook JA, "Neurodegenerative disease and the NLRP3 inflammasome", Front. Pharmacol, 12, pp.643254~ (2021)
- Anderson FL, "NLRP3 inflammasome in neurodegenerative disease", Transl. Res, 252, pp.21~33 (2023)
- Hilliard A, "Involvement of NFkB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS", J. Neuroimmunol, 345, pp.577269~ (2020)
- Cai B, "A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-kappaB and JNK MAPK signaling in microglial BV2 cells", Int. Immunopharmacol, 61, pp.204~214 (2018)
- Kou RW, "Ganoderterpene A, a new triterpenoid from Ganoderma lucidum, attenuates LPS-induced inflammation and apoptosis via suppressing MAPK and TLR-4", NF-kappaB pathways in BV-2 cells, 2021, pp.69, 12730~12740
- Wu Q, "Microglial dysfunction in neurodegenerative diseases via RIPK1 and ROS", Antioxidants(Basel), 11, pp.2201~ (2022)
- Sukjamnong S, "Fimbristylis ovata and Artemisia vulgaris extracts inhibited AGE-mediated RAGE expression, ROS generation, and inflammation in THP-1 cells", Toxicol. Res, 38, pp.331~343 (2022)
- Yang Q, "AGE", RAGE induces primary mouse thyroid epithelial cell apoptosis through the NOX4-ROS pathway, 2024, pp.66, 203~205
- Medeiros ML, "Methylglyoxal exacerbates lipopolysaccharide-induced acute lung injury via RAGE-induced ROS generation : protective effects of metformin", J. Inflamm. Res, 14, pp.6477~6489 (2021)
- Dinkova-Kostova AT, "The role of Nrf2 signaling in counteracting neurodegenerative diseases", FebsJ, 285, pp.3576~3590 (2018)
- Upadhayay S, "Targeting Nrf2", HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions, 2021, pp.3, 100019~
- Almostafa MM, "Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice : the role of Nrf2", HO-1, RAGE, pp.TLR4, NFκB pathways[DOI]
- Luo C, "A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases", Front. Pharmacol, 11, pp.512316~ (2020)